P
OLMA icon

Pitcairn’s Olema Pharmaceuticals OLMA Stock Holding History

Pitcairn’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,532
Closed -$47.1K – 723
2025
Q1 		$47.1K Sell
12,532
-11,496
-48% -$57.8K ﹤0.01% 705
2024
Q4 		$140K Sell
24,028
-518
-2% -$5.17K 0.01% 693
2024
Q3 		$293K Sell
24,546
-2,467
-9% -$31.5K 0.02% 597
2024
Q2 		$292K Buy
+27,013
New +$293K 0.02% 594

Other funds holding OLMA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pitcairn's OLMA Position: Q2 2025 in Review

Pitcairn sold out of Olema Pharmaceuticals (OLMA) in Q2 2025, closing a stake of 12,532 shares — an estimated $47.1K sold.

Pitcairn first reported a position in OLMA in Q2 2024 and held it in 4 quarters. The position peaked at $293K in Q3 2024. 122 funds tracked by Wall St. Rank hold OLMA as of Q2 2025.

  • Pitcairn reported no remaining Olema Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Pitcairn sold 12,532 Olema Pharmaceuticals shares in Q2 2025, an estimated $47.1K.
  • Pitcairn first reported a position in Olema Pharmaceuticals in Q2 2024 and held it in 4 quarters.
  • Pitcairn's Olema Pharmaceuticals position peaked at $293K in Q3 2024.
  • 122 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2025.

Based on Pitcairn's 13F filing for Q2 2025, filed 14 Aug 2025.